Archives

by in
Entry Author Date Location
Zalicus Pain Drug Flops in Two Key Clinical Studies 11/11/13 Boston
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund 08/11/11 Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments 05/17/11 New York
Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News 09/24/10 Boston
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior 09/20/10 Boston
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News 09/17/10 Boston
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks 09/13/10 Boston
Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News 09/10/10 Boston
CombinatoRx Becomes Zalicus 09/09/10 Boston
Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News 04/21/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News 03/05/10 Boston
CombinatoRx Grabs $40M with FDA Approval 03/02/10 Boston
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News 02/12/10 Boston
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup 02/11/10 Boston
CombinatoRx Names New CEO 01/06/10 Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten 10/08/09 Boston
Boston-Area Tech Layoffs Slow: A Recap of Summer’s Job Cuts at Analog Devices, CombinatoRx, and Other Firms 08/17/09 Boston
VMware Springs for SpringSource, Turbine Takes $6.7M, CombinatoRx Teams With Clinical Data, & More Boston-Area Deals News 08/14/09 Boston
$252M Potential in CLDA and CombinatoRx Deal 08/13/09 Boston
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News 07/08/09 Boston
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga 07/06/09 Boston
LogMeIn Pulls Off a $107 million IPO, CombinatoRx To Pair With Neuromed, CloudSwitch Turns on $8M, & More Boston-Area Deals News 07/06/09 Boston
CombinatoRx to Combine with Neuromed, CEO Borisy Steps Down 07/01/09 Boston
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News 05/28/09 Boston
CombinatoRx Diabetes Drug Shows Promise 05/27/09 Boston
Battery Ventures Backs ExactTarget, $22M for Tokai Pharmaceuticals, Ironwood Banks $40M in European Deal, & Much Much More Boston-Area Deals News 05/11/09 Boston
Ironwood Inks $40M Deal with Laboratorios Almirall, CombinatoRx and Novartis Seek Combo Cancer Drugs, NABsys Nabs $4M, & More Boston-Area Life Sciences Deals 05/07/09 Boston
CombinatoRx Cuts Deal for Cancer Drug Discovery with Novartis 05/06/09 Boston
Page 1 of 2 next page »